AGP Picks
View all

Catch up with science and technology news from Haiti

Provided by AGP

Haiti, Science, & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Haiti, Science, & Me.

Press releases published on May 13, 2026

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
Banks Are Moving to a Dual Workforce Model, nCino’s Inaugural AI in Banking Benchmark Shows
AirJoule Technologies Schedules Release of First Quarter 2026 Results and Conference Call
Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston
Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks
Swarmer Reports First Quarter Financial Results
Diginex Appoints Archana Kotecha as Chief Impact Officer to Advance Human Rights and Scale Supply Chain Solutions in a $9.6B Market
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药
Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗,已為首位患者完成給藥
Swarmer Awarded $2.86M Contract to Outfit SkyKnight Drones With Swarming Software
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
BlockBooster Joins Canton Foundation as Official Member, Standing Alongside DTCC, Euroclear, BNP Paribas, and HSBC
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
 Dyne Therapeutics to Participate in Upcoming Investor Conferences
Pyxis Oncology to Participate in Upcoming Investor Conferences
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
Altimmune Announces First Quarter 2026 Financial Results and Business Update

Share us

on your social networks:

Sign up for:

Haiti, Science, & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.